191 related articles for article (PubMed ID: 8212272)
21. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
22. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of malignant ovarian tumors.
Murakami M; Shinozuka T; Kuroshima Y; Tokuda Y; Tajima T
Semin Oncol; 1994 Feb; 21(1 Suppl 1):29-32. PubMed ID: 8153654
[No Abstract] [Full Text] [Related]
23. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
Philip T; Ladenstein R; Zucker JM; Pinkerton R; Bouffet E; Louis D; Siegert W; Bernard JL; Frappaz D; Coze C
Br J Cancer; 1993 Jan; 67(1):119-27. PubMed ID: 8427772
[TBL] [Abstract][Full Text] [Related]
24. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
[TBL] [Abstract][Full Text] [Related]
25. Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.
Dini G; Lanino E; Garaventa A; Paolucci P; Amici A; Locatelli F; Colleselli P; Boni L; Dallorso S; Abla O
Bone Marrow Transplant; 1991; 7 Suppl 2():92. PubMed ID: 1878740
[No Abstract] [Full Text] [Related]
26. [High-dosage melphalan followed by bone marrow autotransplant in solid tumors of childhood: our experience].
Sánchez de Toledo Codina J; Gallego Melcón S; Pérez Payarols J; Prats Viñas J; Javier G; Massuet L; Macià Martí J
Med Clin (Barc); 1986 Apr; 86(15):621-3. PubMed ID: 3014240
[No Abstract] [Full Text] [Related]
27. [Experience of multimodal therapy for advanced neuroblastoma].
Iwata M; Okabe I; Koshinaga T; Hagino N; Morita K; Mugishima H; Kamata R
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1163-6. PubMed ID: 1944178
[TBL] [Abstract][Full Text] [Related]
28. High-dose melphalan, etoposide, and carboplatin (MEC) +/- fractionated total body irradiation for treatment of advanced solid tumors.
Gadner H; Emminger W; Ladenstein R; Peters C
Pediatr Hematol Oncol; 1992; 9(2):v-viii. PubMed ID: 1524986
[No Abstract] [Full Text] [Related]
29. Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.
Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary M; Harris RE; Selch M; Atkinson JB; Haase G; Hammond GD
Prog Clin Biol Res; 1994; 385():301-7. PubMed ID: 7972225
[No Abstract] [Full Text] [Related]
30. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
31. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution.
August CS; Serota FT; Koch PA; Burkey E; Schlesinger H; Elkins WL; Evans AE; D'Angio GJ
J Clin Oncol; 1984 Jun; 2(6):609-16. PubMed ID: 6374056
[TBL] [Abstract][Full Text] [Related]
32. Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor.
Emminger W; Gadner H
Pediatr Hematol Oncol; 1992; 9(2):183-5. PubMed ID: 1356004
[No Abstract] [Full Text] [Related]
33. Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma.
Valteau-Couanet D; Benhamou E; Vassal G; Stambouli F; Lapierre V; Couanet D; Lumbroso J; Hartmann O
Bone Marrow Transplant; 2000 May; 25(9):937-42. PubMed ID: 10800060
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
De Bock R; Nobels F; Schoemaker I; Van der Planken M; Peetermans M
Bone Marrow Transplant; 1989 May; 4(3):331. PubMed ID: 2659119
[No Abstract] [Full Text] [Related]
35. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis.
Imrie KR; Dubé I; Prince HM; Girouard C; Crump M; Keating A
Bone Marrow Transplant; 1998 Feb; 21(4):395-9. PubMed ID: 9509975
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
[TBL] [Abstract][Full Text] [Related]
37. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
Pritchard J; Whelan R; Hill BT
Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
[No Abstract] [Full Text] [Related]
38. [Autologous bone marrow transplantation--its role in the chemotherapy of solid tumor].
Tajima T; Tokuda H; Ota M; Okumura T; Norihisa Y; Kubota M; Yokoyama S; Mitomi T; Kakio S; Tsuji K
Gan No Rinsho; 1989 May; Spec No():303-11. PubMed ID: 2601018
[No Abstract] [Full Text] [Related]
39. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
Flandin I; Hartmann O; Michon J; Pinkerton R; Coze C; Stephan JL; Fourquet B; Valteau-Couanet D; Bergeron C; Philip T; Carrie C
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1424-31. PubMed ID: 16427213
[TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow transplantation. A maximal therapy design for disseminated neuroblastoma.
Helson L
Am J Pediatr Hematol Oncol; 1985; 7(1):45-50. PubMed ID: 3898900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
